ASCO GI Conference Page Header

Article

Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Check out the stories below for write-ups of the most important information to come out of this year's event.

Cancer Network presents exclusive coverage from the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Check out the stories below for write-ups of the most important information to come out of this year's event.

Related Videos
A panel of 3 experts on multiple myeloma
A panel of 3 experts on multiple myeloma
Aparna Parikh, MD, with the Oncology Brothers presenting slides
Aparna Parikh, MD, with the Oncology Brothers presenting slides
Aparna Parikh, MD, with the Oncology Brothers presenting slides
Aparna Parikh, MD, with the Oncology Brothers presenting slides
Aparna Parikh, MD, with the Oncology Brothers presenting slides
Tailoring neoadjuvant therapy regimens for patients with mismatch repair deficient gastroesophageal cancer represents a future step in terms of research.
Related Content
Increased Thyroid Cancer Risk Not Observed After Use of GLP1 Receptor Agonist

Increased Thyroid Cancer Risk Not Observed After Use of GLP1 Receptor Agonist

April 16th 2024
Article

Patients who are predisposed to medullary thyroid cancer should be advised against the use of GLP1 agents.

Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.

Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care

April 15th 2024
Podcast

Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.

Evaluation and Management of Testicular Cancer After Late Relapse

Evaluation and Management of Testicular Cancer After Late Relapse

April 16th 2024
Article

The clinical quandary by Langer et al discusses a contralateral late relapse of the original right nonseminomatous germ cell tumors.

Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.

Finding Ways to Break the Mold in GU Oncology

April 8th 2024
Podcast

Leaders in genitourinary oncology spoke about key research advances as well as personal experiences in navigating the field.

STARGLO Trial Meets OS End Point With Glofitamab in Relapsed/Refractory DLBCL

STARGLO Trial Meets OS End Point With Glofitamab in Relapsed/Refractory DLBCL

April 15th 2024
Article

Additional data and results from the phase 3 STARGLO trial of glofitamab for patients with relapsed/refractory diffuse large B-cell lymphoma will be presented at an upcoming medical meeting.

Sacituzumab Tirumotecan Shows Early Efficacy in Gastric/GEJ Cancers

Sacituzumab Tirumotecan Shows Early Efficacy in Gastric/GEJ Cancers

April 15th 2024
Article

Sacituzumab tirumotecan elicited responses prominently in the second- and third-line and beyond setting and in those with high TROP2 expression.